Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista de la Sociedad Española del Dolor
versión impresa ISSN 1134-8046
Resumen
MEDINA PEREZ, JJ; VEGA ROSAS, GA; MEDINA PEREZ, ME y COUBERT PELAYO, SG. Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome. Rev. Soc. Esp. Dolor [online]. 2021, vol.28, n.2, pp.71-75. Epub 21-Jun-2021. ISSN 1134-8046. https://dx.doi.org/10.20986/resed.2021.3822/2020.
Objective:
The objective of this study is to evaluate the efficacy and safety of long-acting tapentadol 100 or 200 mg orally every 24 hours for the treatment of Postlaminectomy Syndrome (SPL) in a series of patients with pain neuropathic in ineffective analgesic treatment.
Material and methods:
A single-center, longitudinal, prospective and observational study was conducted, in which 30 patients were recruited to the pain clinic of a third-level reference center who suffered from SPL and who met all the inclusion criteria; To whom the Brief Pain Inventory questionnaire in its Spanish version and the Lanss Test were applied before and after starting treatment with tapentadol and a student's t was applied to compare the overall effectiveness of the treatment of neuropathic pain.
Results:
Data from 30 patients were analyzed, of which 19 were women (63.3 %) and 11 were men (36.6 %) with a diagnosis of confirmed SPL and the presentation of neuropathic pain, who were divided into two groups. The first group of 13 patients (43.3 %) received tapentadol at 100 mg orally every 24 hours, and the second group of 17 patients (56.6 %) received 200 mg orally every 24 hours for four weeks. They were followed up for 4 weeks and statistically significant improvement (p value = 0.05) was found in the SPL clinic.
Palabras clave : Neuropathic pain; chronic pain; postlaminectomy syndrome; tapentadol; opioids; orthopedic surgery.